New and established tyrosine kinase inhibitors for chronic myeloid leukemia. [electronic resource]
Producer: 20121113Description: 601-13 p. digitalISSN:- 1699-3993
- Aniline Compounds -- adverse effects
- Benzamides
- Dasatinib
- Humans
- Imatinib Mesylate
- Leukemia, Myelogenous, Chronic, BCR-ABL Positive -- drug therapy
- Nitriles -- adverse effects
- Piperazines -- adverse effects
- Protein Kinase Inhibitors -- therapeutic use
- Protein-Tyrosine Kinases -- antagonists & inhibitors
- Pyrimidines -- adverse effects
- Quinolines -- adverse effects
- Thiazoles -- adverse effects
No physical items for this record
Publication Type: Journal Article; Review
There are no comments on this title.
Log in to your account to post a comment.